Literature DB >> 8378246

Increased sensitivity to the anticonvulsant effect of valproate in aging BN/BiRij rats.

A M Stijnen1, S Hovinga, M W Langemeijer, A Hoogerkamp, C F van Bezooijen, M Danhof.   

Abstract

The aim of the present investigations was to study the influence of increasing age on the pharmacodynamics of valproate in BN/BiRij rats, applying a threshold for electrically induced localized seizure activity as a measure of the anticonvulsant effect. Seven groups of healthy male BN/BiRij rats were used, aged 3, 6, 12, 19, 25, 31, and 37 months. Individual plasma concentration versus anticonvulsant effect relationships were determined during a continuous intravenous infusion of sodium valproate at a rate of 5.5 mg/min/kg. The infusion was terminated when the anticonvulsant effect intensity had reached the maximum attainable level or at a total infusion time of three hours. A nonlinear relationship between valproate concentration and anticonvulsant effect intensity was observed with no maximal effect in the concentration range up to 1200 mg.L-1. With increasing age a parallel shift in the concentration versus anticonvulsant effect relationships toward lower concentrations occurred. Thus increasing age appears to be associated with an increased sensitivity to the anticonvulsant effect of valproate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8378246     DOI: 10.1023/a:1018975025417

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

1.  Sodium valproate and the liver.

Authors: 
Journal:  Lancet       Date:  1980-11-22       Impact factor: 79.321

2.  The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models.

Authors:  W Löscher; C P Fassbender; B Nolting
Journal:  Epilepsy Res       Date:  1991-03       Impact factor: 3.045

Review 3.  Age-related differences in the coordination disturbance and anticonvulsant effect of oxazepam in mice.

Authors:  K Kitani; U Klotz; S Kanai; Y Sato; M Ohta; M Nokubo
Journal:  Arch Gerontol Geriatr       Date:  1989-07       Impact factor: 3.250

4.  Impaired growth hormone response to sodium valproate in normal aging.

Authors:  P Monteleone; M Iovino; F Orio; L Steardo
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Valproic acid-induced hyperammonemia in mentally retarded adults.

Authors:  C A Williams; S Tiefenbach; J W McReynolds
Journal:  Neurology       Date:  1984-04       Impact factor: 9.910

6.  Pharmacokinetics of valproic acid in the elderly.

Authors:  E Perucca; R Grimaldi; G Gatti; S Pirracchio; F Crema; G M Frigo
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

7.  Pharmacokinetics of valproic acid in young and elderly subjects.

Authors:  S M Bryson; N Verma; P J Scott; P C Rubin
Journal:  Br J Clin Pharmacol       Date:  1983-07       Impact factor: 4.335

8.  Properties of the convulsive threshold determined by direct cortical stimulation in rats.

Authors:  R A Voskuyl; A Hoogerkamp; M Danhof
Journal:  Epilepsy Res       Date:  1992-07       Impact factor: 3.045

9.  Mitochondrial metabolism of valproic acid.

Authors:  J Li; D L Norwood; L F Mao; H Schulz
Journal:  Biochemistry       Date:  1991-01-15       Impact factor: 3.162

Review 10.  Formation of active metabolites of anticonvulsant drugs. A review of their pharmacokinetic and therapeutic significance.

Authors:  M J Eadie
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.